Recent Advances in Gastrointestinal Cancers

In this video, oncologist Ursina Teitelbaum, MD, provides an overview of reports from ASCO on the current state of  targeted therapies for cancers of the colon, pancreas, stomach and liver. Dr. Teitelbaum discusses studies of bevacizumab, cetuximab and the FOLFOX and FOLFIRI regimens in colorectal cancer; ruxolitinib, capecitabine and mGPS in pancreatic cancer; capecitabine, cisplatin, bevacizumab, ramucirumab and paclitaxel in the gastric cancers; and sorafenib in hepatocellular carcinoma.

 

 

Related Links

Related Videos